Study guide

2.1 Primary & Secondary Immunodeficiencies

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

2.1 Primary & Secondary Immunodeficiencies

Key Takeaways Explain This Topic AI

X-linked agammaglobulinemia (XLA/Bruton) presents after 6 months of age with <2% CD19+ B cells, pan-hypogammaglobulinemia, absent tonsils/lymph nodes, and recurrent sinopulmonary bacterial infections.

Common Variable Immunodeficiency (CVID) manifests in young adults (ages 20–40) with reduced IgG/IgA/IgM, normal B cell counts, and elevated risk for autoimmune disease and lymphoma; Selective IgA deficiency is often asymptomatic but carries risk for anaphylactic transfusion reactions due to anti-IgA antibodies.

Severe Combined Immunodeficiency (SCID) presents in infants (<6 months) with failure to thrive, chronic diarrhea, persistent candidiasis, absolute lymphocyte count <1,500/mm³, and absent thymic shadow on chest radiograph.

Chronic Granulomatous Disease (CGD) results from defective NADPH oxidase, predisposing patients to recurrent catalase-positive bacterial and fungal infections, and is diagnosed via dihydrorhodamine (DHR) flow cytometry showing absent respiratory burst.

Secondary immunodeficiencies are far more prevalent than primary immunodeficiencies; AIDS is diagnosed when CD4+ T-cell count falls below 200 cells/mm³ or upon presentation with an AIDS-defining opportunistic illness (e.g., Pneumocystis jirovecii pneumonia, Kaposi sarcoma).

Last updated: July 2026

  • Primary & Secondary Immunodeficiencies
  • Introduction & Diagnostic Architecture

Immunodeficiencies represent disorders of immune system component failure, divided into primary immunodeficiencies (PIDs) —inherited genetic defects usually presenting in infancy or childhood—and secondary immunodeficiencies , which result from extrinsic factors such as HIV/AIDS , malnutrition, immunosuppressive pharmacotherapy, malignancies (e.g., multiple myeloma, CLL), or post-splenectomy states. On USMLE Step 2 CK, clinical vignettes emphasize matching age of onset, specific pathogen susceptibility patterns, characteristic physical exam findings, and quantitative laboratory markers to narrow the differential diagnosis and initiate appropriate therapy.

Classification of Immunodeficiencies by Immune Arm

Immune Component Primary Defect Examples Susceptible Pathogens Characteristic Lab Findings

Humoral (B-Cell) X-linked Agammaglobulinemia, CVID, Selective IgA Deficiency Encapsulated bacteria ( S. pneumoniae , H. influenzae , N. meningitidis ), Giardia lamblia Decreased Ig levels, decreased CD19/CD20+ B cells, absent germinal centers

Cellular (T-Cell) DiGeorge Syndrome, IL-12 Receptor Deficiency Viruses (CMV, VZV, HSV), fungi ( Candida , PCP ), mycobacteria Decreased CD3+ T cells, delayed-type hypersensitivity skin test negativity

Combined (B & T) SCID, Wiskott-Aldrich Syndrome, Ataxia-Telangiectasia Bacteria, viruses, fungi, protozoa Low ALC (<1,500/mm³), low immunoglobulins, absent thymic shadow

Phagocytic Chronic Granulomatous Disease, Leukocyte Adhesion Deficiency, Chédiak-Higashi Catalase-positive organisms ( S. aureus , Pseudomonas , Aspergillus , Serratia ) Abnormal DHR assay, persistent neutrophilia without pus formation, giant granules

Complement Early components (C1q, C2, C4), Late components (C5-C9) Encapsulated bacteria (C1-C4), Neisseria species (C5-C9) Low CH50 assay, low individual complement component levels

  • Primary B-Cell (Humoral) Immunodeficiencies
  • X-Linked Agammaglobulinemia (Bruton Agammaglobulinemia)

X-linked agammaglobulinemia (XLA) is caused by a loss-of-function mutation in the Bruton tyrosine kinase (BTK) gene, halting pre-B cell maturation into mature B cells in the bone marrow. Symptoms manifest after 6 months of age , as protective maternal IgG antibodies decay. Patients suffer from recurrent sinopulmonary bacterial infections ( Streptococcus pneumoniae , non-typeable Haemophilus influenzae ) and enteroviral infections (poliovirus, echovirus). Physical examination reveals absent tonsils and lymph nodes . Flow cytometry shows <2% CD19+ mature B cells with markedly decreased levels of all immunoglobulin classes (IgG, IgA, IgM, IgE). Treatment requires lifelong intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) replacement and prophylactic antibiotics. Live vaccines are strictly contraindicated .

Common Variable Immunodeficiency (CVID)

Common Variable Immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency presenting in late adolescence or early adulthood (ages 20–40) . The underlying cause involves heterogeneous defects in B-cell differentiation and plasma cell survival. Patients exhibit recurrent sinopulmonary infections, bronchiectasis, chronic diarrhea ( Giardia ), and a high incidence of autoimmune diseases (e.g., immune thrombocytopenia, autoimmune hemolytic anemia) and malignancies (especially non-Hodgkin lymphoma and gastric adenocarcinoma). Laboratory findings demonstrate low serum IgG alongside low IgA or IgM, with poor antibody response to vaccination. Management relies on IVIG/SCIG therapy.

Selective IgA Deficiency

Selective IgA Deficiency is the most frequent primary immunodeficiency overall, occurring in approximately 1 in 500 individuals. Most patients are asymptomatic ; however, symptomatic individuals present with recurrent mucosal infections (sinusitis, bronchitis) and chronic diarrhea. Crucially, up to 30% of patients develop anti-IgA antibodies . If transfused with blood products containing IgA, these individuals can experience severe, potentially fatal anaphylactic transfusion reactions . Diagnosis is confirmed by serum IgA <7 mg/dL with normal IgG and IgM levels. Treatment involves prompt management of infections; washed red blood cells or IgA-deficient blood products must be utilized for transfusions.

  • Combined & Cell-Mediated Immunodeficiencies
  • Severe Combined Immunodeficiency (SCID)

Severe Combined Immunodeficiency (SCID) is a pediatric medical emergency caused by mutations such as X-linked IL-2 receptor gamma chain deficiency (most common) or autosomal recessive adenosine deaminase (ADA) deficiency . Adenosine deaminase deficiency leads to toxic accumulation of dATP, inhibiting ribonucleotide reductase and destroying lymphocytes. Infants present within the first 6 months of life with severe failure to thrive, intractable diarrhea, persistent oral candidiasis, and life-threatening infections caused by bacterial, viral, fungal, and protozoal pathogens (e.g., Pneumocystis jirovecii ). Chest radiography demonstrates an absent thymic shadow . Absolute lymphocyte count is typically <1,500/mm³ . Definitive treatment is hematopoietic stem cell transplantation (HSCT) before 3.5 months of age to ensure survival.

DiGeorge Syndrome (22q11.2 Deletion)

DiGeorge syndrome stems from microdeletion of chromosome 22q11.2 , impairing development of the 3rd and 4th pharyngeal pouches . The classic clinical triad includes:

  • Conotruncal cardiac defects (Tetralogy of Fallot, truncus arteriosus)
  • Hypoparathyroidism producing hypocalcemia and neonatal tetany
  • Thymic aplasia/hypoplasia causing T-cell immunodeficiency

Laboratory evaluation shows decreased CD3+ T cells with normal immunoglobulin levels unless T-cell help is compromised. Management includes correction of hypocalcemia, cardiac repair, and thymic transplantation or HSCT for severe immunodeficiency.

  • Phagocytic Defects & Secondary Immunodeficiencies
  • Chronic Granulomatous Disease (CGD)

Chronic Granulomatous Disease (CGD) is predominantly an X-linked recessive disorder caused by mutations in NADPH oxidase , impairing the generation of reactive oxygen species (superoxide radicals) within phagocytes to execute the respiratory burst. Patients are highly susceptible to catalase-positive organisms that degrade endogenous bacterial hydrogen peroxide: Staphylococcus aureus , Pseudomonas cepacia , Serratia marcescens , Aspergillus species, and Nocardia . Recurrent granuloma formation leads to skin abscesses, lymphadenitis, hepatic abscesses, and osteomyelitis. The diagnostic standard is the dihydrorhodamine (DHR) flow cytometry assay (showing lack of fluorescence conversion) or the historic nitroblue tetrazolium (NBT) reduction test . Treatment includes lifelong daily trimethoprim-sulfamethoxazole and itraconazole prophylaxis, along with interferon-gamma injections.

  • Diagnostic Evaluation Algorithm for Suspected Immunodeficiency Suspected Recurrent / Severe Infections
  • ├─ Initial Screen: CBC with differential (ALC, ANC), Quantitative immunoglobulins (IgG, IgA, IgM, IgE)
  • │
  • ├─ Recurrent Sinopulmonary (Humoral Suspicion)
  • │ └─ Flow Cytometry (CD19/CD20 B cells) + Specific Antibody Response (Tetanus, Pneumococcal)
  • │ ├─ Decreased IgG/IgA/IgM + <2% B cells → XLA (Bruton)
  • │ └─ Decreased IgG/IgA/IgM + Normal B cells → CVID
  • │
  • ├─ Early Infant / Opportunistic Infections (Combined Suspicion)
  • │ └─ Flow Cytometry (CD3/CD4/CD8 T cells, CD19 B cells, CD56 NK cells) + Chest X-ray
  • │ ├─ ALC <1,500/mm³ + Absent Thymic Shadow → SCID
  • │ └─ Decreased CD3+ T cells + Hypocalcemia + Conotruncal Heart Defect → DiGeorge Syndrome
  • │
  • └─ Catalase-Positive Infections / Abscesses (Phagocytic Suspicion)
  • └─ Dihydrorhodamine (DHR) Flow Cytometry Assay
  • ├─ Absent DHR fluorescence → Chronic Granulomatous Disease (CGD)
  • └─ Neutrophilia without pus at umbilical cord site → Leukocyte Adhesion Deficiency (LAD)